<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>衛生福利部食品藥物管理署 - 中文版 - 管制藥品類</title><description>衛生福利部食品藥物管理署 - 中文版 - 管制藥品類</description><link>http://www.fda.gov.tw/tc/index.aspx</link><lastBuildDate>Sat, 14 Mar 2026 22:21:13 GMT</lastBuildDate><docs>http://backend.userland.com/rss</docs><generator>衛生福利部食品藥物管理署</generator><item><title>公告修正管制藥品品項(增修Propoxate等12項管制藥品)</title><link>http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=31332</link><description>&lt;![CDATA[http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=31332]]&gt;</description><pubDate>Thu, 04 Dec 2025 00:00:00 GMT</pubDate></item><item><title>修正「第一級第二級管制藥品限量核配辦法」第二條附表</title><link>http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=31208</link><description>&lt;![CDATA[http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=31208]]&gt;</description><pubDate>Thu, 11 Sep 2025 00:00:00 GMT</pubDate></item><item><title>公告修正管制藥品品項(增修丁托咪酯等7項管制藥品)</title><link>http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=31182</link><description>&lt;![CDATA[http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=31182]]&gt;</description><pubDate>Mon, 25 Aug 2025 00:00:00 GMT</pubDate></item><item><title>公告修正管制藥品品項(增修正丙帕酯等14項管制藥品)</title><link>http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=31080</link><description>&lt;![CDATA[http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=31080]]&gt;</description><pubDate>Tue, 27 May 2025 00:00:00 GMT</pubDate></item><item><title>公告修正管制藥品品項(增列布托尼他淨等3項管制藥品)</title><link>http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=30940</link><description>&lt;![CDATA[http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=30940]]&gt;</description><pubDate>Thu, 06 Feb 2025 00:00:00 GMT</pubDate></item><item><title>公告修正管制藥品品項(增修美托咪酯等2項管制藥品)</title><link>http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=30819</link><description>&lt;![CDATA[http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=30819]]&gt;</description><pubDate>Thu, 14 Nov 2024 00:00:00 GMT</pubDate></item><item><title>公告修正管制藥品品項(增修四氫大麻己酚等5項管制藥品)</title><link>http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=30668</link><description>&lt;![CDATA[http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=30668]]&gt;</description><pubDate>Fri, 02 Aug 2024 00:00:00 GMT</pubDate></item><item><title>公告修正管制藥品品項(增列3-側氧基-2-苯基丁醯胺等3項管制藥品)</title><link>http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=30626</link><description>&lt;![CDATA[http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=30626]]&gt;</description><pubDate>Tue, 25 Jun 2024 00:00:00 GMT</pubDate></item><item><title>公告修正管制藥品品項(增列1-甲基苯基-1-丙酮等5項管制藥品，並修正3,4-亞甲基雙氧苯基甲胺戊酮、氯二氮平、苯巴比妥等3項管制藥品)</title><link>http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=29086</link><description>&lt;![CDATA[http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=29086]]&gt;</description><pubDate>Tue, 12 Sep 2023 00:00:00 GMT</pubDate></item><item><title>公告修正管制藥品品項(增列α-吡咯烷基苯異己酮等11項管制藥品，並修正裸頭草辛等2項管制藥品)</title><link>http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=28780</link><description>&lt;![CDATA[http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=28780]]&gt;</description><pubDate>Tue, 25 Apr 2023 00:00:00 GMT</pubDate></item><item><title>公告修正管制藥品品項(增列墨西哥鼠尾草(Salvia divinorum)等12項管制藥品)</title><link>http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=28349</link><description>&lt;![CDATA[http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=28349]]&gt;</description><pubDate>Mon, 31 Oct 2022 00:00:00 GMT</pubDate></item><item><title>公告修正管制藥品品項(增列異丁醯吩坦尼(Isobutyrfentanyl)等299項管制藥品)</title><link>http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=27744</link><description>&lt;![CDATA[http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=27744]]&gt;</description><pubDate>Tue, 08 Mar 2022 00:00:00 GMT</pubDate></item><item><title>醫師為非癌症慢性頑固性疼痛病人長期處方成癮性麻醉藥品使用指引暨管理注意事項(衛生福利部食品藥物管理署111 年 1 月 13 日 FDA 管字第 1101860033 號函修訂)</title><link>http://www.fda.gov.tw/tc/lawContent.aspx?cid=183&amp;id=3370</link><description>&lt;![CDATA[&lt;span style="font-size: 12pt; font-family: &amp;quot;新細明體&amp;quot;, serif; mso-bidi-font-size: 11.0pt; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-fareast-theme-font: minor-fareast; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: &amp;quot;Times New Roman&amp;quot;; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"&gt;醫師為非癌症慢性頑固性疼痛病人長期處方成癮性麻醉藥品使用指引暨管理注意事項&lt;/span&gt;&lt;span lang="EN-US" style="font-size: 12pt; font-family: &amp;quot;Calibri&amp;quot;, sans-serif; mso-bidi-font-size: 11.0pt; mso-ascii-theme-font: minor-latin; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: &amp;quot;Times New Roman&amp;quot;; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; mso-fareast-font-family: 新細明體"&gt;(&lt;/span&gt;&lt;span style="font-size: 12pt; font-family: &amp;quot;新細明體&amp;quot;, serif; mso-bidi-font-size: 11.0pt; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-fareast-theme-font: minor-fareast; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: &amp;quot;Times New Roman&amp;quot;; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"&gt;衛生福利部食品藥物管理署&lt;/span&gt;&lt;span lang="EN-US" style="font-size: 12pt; font-family: &amp;quot;Calibri&amp;quot;, sans-serif; mso-bidi-font-size: 11.0pt; mso-ascii-theme-font: minor-latin; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: &amp;quot;Times New Roman&amp;quot;; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; mso-fareast-font-family: 新細明體"&gt;111 &lt;/span&gt;&lt;span style="font-size: 12pt; font-family: &amp;quot;新細明體&amp;quot;, serif; mso-bidi-font-size: 11.0pt; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-fareast-theme-font: minor-fareast; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: &amp;quot;Times New Roman&amp;quot;; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"&gt;年&lt;/span&gt;&lt;span lang="EN-US" style="font-size: 12pt; font-family: &amp;quot;Calibri&amp;quot;, sans-serif; mso-bidi-font-size: 11.0pt; mso-ascii-theme-font: minor-latin; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: &amp;quot;Times New Roman&amp;quot;; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; mso-fareast-font-family: 新細明體"&gt; 1 &lt;/span&gt;&lt;span style="font-size: 12pt; font-family: &amp;quot;新細明體&amp;quot;, serif; mso-bidi-font-size: 11.0pt; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-fareast-theme-font: minor-fareast; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: &amp;quot;Times New Roman&amp;quot;; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"&gt;月&lt;/span&gt;&lt;span lang="EN-US" style="font-size: 12pt; font-family: &amp;quot;Calibri&amp;quot;, sans-serif; mso-bidi-font-size: 11.0pt; mso-ascii-theme-font: minor-latin; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: &amp;quot;Times New Roman&amp;quot;; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; mso-fareast-font-family: 新細明體"&gt; 13 &lt;/span&gt;&lt;span style="font-size: 12pt; font-family: &amp;quot;新細明體&amp;quot;, serif; mso-bidi-font-size: 11.0pt; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-fareast-theme-font: minor-fareast; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: &amp;quot;Times New Roman&amp;quot;; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"&gt;日&lt;/span&gt;&lt;span lang="EN-US" style="font-size: 12pt; font-family: &amp;quot;Calibri&amp;quot;, sans-serif; mso-bidi-font-size: 11.0pt; mso-ascii-theme-font: minor-latin; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: &amp;quot;Times New Roman&amp;quot;; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; mso-fareast-font-family: 新細明體"&gt; FDA &lt;/span&gt;&lt;span style="font-size: 12pt; font-family: &amp;quot;新細明體&amp;quot;, serif; mso-bidi-font-size: 11.0pt; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-fareast-theme-font: minor-fareast; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: &amp;quot;Times New Roman&amp;quot;; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"&gt;管字第&lt;/span&gt;&lt;span lang="EN-US" style="font-size: 12pt; font-family: &amp;quot;Calibri&amp;quot;, sans-serif; mso-bidi-font-size: 11.0pt; mso-ascii-theme-font: minor-latin; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: &amp;quot;Times New Roman&amp;quot;; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; mso-fareast-font-family: 新細明體"&gt; 1101860033 &lt;/span&gt;&lt;span style="font-size: 12pt; font-family: &amp;quot;新細明體&amp;quot;, serif; mso-bidi-font-size: 11.0pt; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-fareast-theme-font: minor-fareast; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: &amp;quot;Times New Roman&amp;quot;; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"&gt;號函修訂&lt;/span&gt;&lt;span lang="EN-US" style="font-size: 12pt; font-family: &amp;quot;Calibri&amp;quot;, sans-serif; mso-bidi-font-size: 11.0pt; mso-ascii-theme-font: minor-latin; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: &amp;quot;Times New Roman&amp;quot;; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; mso-fareast-font-family: 新細明體"&gt;)&lt;/span&gt;]]&gt;</description><pubDate>Mon, 17 Jan 2022 00:00:00 GMT</pubDate></item><item><title>公告修正管制藥品品項(增列2-Amino-5-nitrobenzophenone、Benzylfentanyl及2-Iodo-4-methylpropiophenone)</title><link>http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=27388</link><description>&lt;![CDATA[http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=27388]]&gt;</description><pubDate>Fri, 08 Oct 2021 00:00:00 GMT</pubDate></item><item><title>苯二氮平類(Benzodiazepines)藥品用於鎮靜安眠之使用指引(96年10月03日公告修訂)</title><link>http://www.fda.gov.tw/tc/lawContent.aspx?cid=183&amp;id=3350</link><description>&lt;![CDATA[苯二氮平類(Benzodiazepines)藥品用於鎮靜安眠之使用指引(96年10月03日公告修訂)]]&gt;</description><pubDate>Wed, 06 Oct 2021 00:00:00 GMT</pubDate></item><item><title>吩坦尼穿皮貼片劑治療疼痛使用指引暨管理注意事項(107年12月4日修訂)</title><link>http://www.fda.gov.tw/tc/lawContent.aspx?cid=183&amp;id=3348</link><description>&lt;![CDATA[吩坦尼穿皮貼片劑治療疼痛使用指引暨管理注意事項(107年12月4日修訂)]]&gt;</description><pubDate>Wed, 06 Oct 2021 00:00:00 GMT</pubDate></item><item><title>公告修正管制藥品品項(修正2C-E、Fluoro-α-PHP英文名稱及增列4-AP)</title><link>http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=27134</link><description>&lt;![CDATA[http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=27134]]&gt;</description><pubDate>Thu, 10 Jun 2021 00:00:00 GMT</pubDate></item><item><title>公告修正管制藥品品項(增列N-Butylpentylone、N-Butylhexedrone、Methyl-3-oxo-2-phenylbutyrate、Fluorophenylacetone及Methoxyphenylacetone)</title><link>http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=26537</link><description>&lt;![CDATA[http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=26537]]&gt;</description><pubDate>Mon, 16 Nov 2020 00:00:00 GMT</pubDate></item><item><title>公告修正管制藥品品項(增列Chloro-α-PPP、2-DCNEK、EEC、…等20項)</title><link>http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=25810</link><description>&lt;![CDATA[http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=25810]]&gt;</description><pubDate>Thu, 05 Dec 2019 00:00:00 GMT</pubDate></item><item><title>公告修正管制藥品品項(增列Khat、2C-E、AB-PINACA、EMC及Mitragynine)</title><link>http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=25089</link><description>&lt;![CDATA[http://www.fda.gov.tw/TC/newsContent.aspx?cid=3&amp;id=25089]]&gt;</description><pubDate>Thu, 11 Apr 2019 00:00:00 GMT</pubDate></item></channel></rss>